How to Expand CD34+ Hematopoietic Stem and Progenitor Cells Using StemSpan™ HSPC Medium
Human CD34+ hematopoietic stem and progenitor cells (HSPCs) are widely used in hematopoietic cell transplantation, gene editing, and cell therapy development. However, obtaining sufficient numbers of HSPCs while maintaining primitive hematopoietic stem cells (HSCs) during ex vivo culture remains a significant challenge, particularly when working with limited starting material such as cord blood. Robust and reproducible expansion workflows are therefore critical for research and cell manufacturing applications.
This protocol describes how to culture and expand human CD34+ HSPCs using STEMdiff™ Hematopoietic - EB reagents, a serum-free, phenol red-free, cytokine-free medium manufactured under relevant GMP guidelines. HSPCs can be isolated from cord blood (CB), bone marrow (BM), or mobilized peripheral blood (mPB) and cultured with recommended StemSpan™ expansion supplements or user-defined cytokine and small molecule combinations. Using this workflow, researchers can support robust expansion of CD34+ HSPCs while maintaining primitive HSC populations characterized by a CD34+CD45RA-CD90+EPCR+ phenotype. The protocol provides a flexible foundation for HSPC expansion, genome editing workflows, and cell therapy process development where scalable, reproducible hematopoietic cell culture is required.
Materials
Required Materials
- StemSpan™ HSPC Medium (Catalog #100-1791)
- StemSpan™ CD34+ Expansion Supplement (10X) (Catalog #02691)
- Supplement to enhance hematopoietic cell expansion i.e. UM729 (Catalog #72332) or StemSpan™ HSC Plus Supplement (100X) (Catalog #100-1694)
- Serological pipettes
- Micropipette tips
- Culture vessel* selected from:
- 6-Well Flat-Bottom Plate (Catalog #38040)
- 24-well Flat-Bottom Plate (Catalog #38042)
- 96-Well Flat-Bottom Plate (Catalog #38018)
* Both tissue culture-treated and non-tissue culture-treated are suitable for HSPC expansion.
Additional and Optional Materials
- Materials for cell counting, i.e. Nucleocounter® NC-250™ (ChemoMetec; Product #970-0251) Viability and Cell Count Assay Protocol:
- Sampling slides i.e. NC-Slide A2™ (ChemoMetec; Product #942-0001) or NC-Slide A8™ (ChemoMetec; Product #942-0003)
- Solution 18 (ChemoMetec; Product #910-3018)
- Eppendorf tubes
- Reagents for flow cytometry assessment:
- Anti-Human CD34 Antibody, Clone 581 (Catalog #60013) or Clone 563 (Catalog #60119) or Clone 8G12 (Catalog #60121)
- Anti-Human CD45RA Antibody, Clone HI100 ()
- Anti-Human CD90 Antibody, Clone 5E10 (Catalog #60045)
- Anti-Human EPCR Antibody, Clone RCR-401
- MethoCult™ H4435 Enriched medium (Catalog #04435)
Preparation of Reagents and Culture Medium (Day 0)
StemSpan™ HSPC Medium supplemented with StemSpan™ CD34+ Expansion Supplement (10X) is used for culture initiation and medium top-up during HSPC expansion (Days 0 - 7). Using sterile technique, prepare the complete medium as described below; optional supplementation with StemSpan™ HSC Plus Supplement or UM729 may be used to support expansion of more primitive populations
- Thaw StemSpan™ HSPC Medium at 37°C, room temperature (15 - 25°C), or overnight at 2 - 8°C. Mix thoroughly immediately after thawing. Bring to room temperature before use.
Note: If any precipitate is observed after thawing, mix thoroughly to dissolve. Once thawed, use immediately or aliquot and store at -20°C until expiry date (EXP) on label. After thawing aliquots, use immediately. Do not refreeze.
- Thaw StemSpan™ CD34+ Expansion Supplement (10X) at room temperature (15 - 25°C). Mix thoroughly.
Note: Once thawed, store supplement at 2 - 8°C for up to 1 month. Alternatively, aliquot and store at -20°C. After thawing aliquots, store at 2 - 8°C for up to 1 month; do not re-freeze. Do not exceed the product shelf life.
- Prepare complete medium by adding StemSpan™ CD34+ Expansion Supplement (10X) to StemSpan™ HSPC Medium at a 1:10 dilution (e.g. add 10 mL of supplement to 90 mL of medium). Mix thoroughly.
- Optional: Selected small molecules can further enhance expansion of CD34+ cells and primitive HSPC subsets, including CD34+CD45RA-CD90+EPCR+ cells. Add one of the following supplements to the complete medium prepared in Step 3:
- Add UM729 to complete medium at a final concentration of 1 μM. Titration may be required to determine the optimal concentration for CD34+ cell expansion.
OR - Add StemSpan™ HSC Plus Supplement (100X) to complete medium at a 1:100 dilution (e.g. add 1 mL of supplement to 99 mL of medium). Mix thoroughly.
- Add UM729 to complete medium at a final concentration of 1 μM. Titration may be required to determine the optimal concentration for CD34+ cell expansion.
Preparation of CD34+ HSPCs (Day 0)
Prepare a single-cell suspension of CD34+ HSPCs using one of the following approaches. Once cells have been prepared, proceed to Cell Counting and Seeding of HSPCs (Day 0).
Isolating CD34+ HSPCs
Isolate CD34+ HPSCs from fresh whole CB, BM, mPB, or frozen mononuclear cells (MNCs), using the recommended cell isolation kits shown in Table 1. Proceed to Cell Counting and Seeding of HSPCs (Day 0) following isolation.
Table 1. Recommended Cell Isolation Kits for Various Cell Sources
| Cell Source | Recommended Cell Isolation Kit |
|---|---|
| Fresh whole cord blood | EasySep™ Human Cord Blood CD34 Positive Selection Kit II (Catalog #17896) |
| Fresh bone marrow (e.g. Human Whole Bone Marrow, Fresh, Catalog #70502*) | EasySep™ Human CD34 Positive Selection Kit II (Catalog #17856) |
| Fresh mobilized peripheral blood (mobilized with G-CSF, plerixafor, or a combination; e.g. Human Mobilized Peripheral Blood Leukopak, G-CSF, Fresh, Catalog #200-0602*) | EasySep™ Human CD34 Positive Selection Kit II (Catalog #100-1569) |
| Frozen mononuclear cells from bone marrow (e.g. Human Bone Marrow Mononuclear Cells, Frozen, Catalog #70001*) | EasySep™ Human CD34 Positive Selection Kit II (Catalog #17856) |
| Frozen mononuclear cells from cord blood (e.g. Human Cord Blood Mononuclear Cells, Frozen, Catalog #70007*) | |
| Frozen mononuclear cells from mobilized peripheral blood (e.g. G-CSF Mobilized Human Peripheral Blood Mononuclear Cells, Frozen, Catalog #70049*) |
*Some primary cell products are available only in select regions. Contact us at techsupport@stemcell.com for further information.
Thawing Cryopreserved CD34+ HSPCs
Previously isolated cryopreserved CD34+ HSPCs may be sourced from BM, CB, or mPB. Following thaw, proceed to Cell Counting and Seeding of CD34+ HSPCs (Day 0).
- Thaw a cryovial of CD34+ HSPCs in a 37°C water bath until a small sliver of ice remains.
- Add cells dropwise to a tube containing 10 mL of StemSpan™ HSPC Medium.
- Rinse cryovial with 1 mL of StemSpan™ HSPC Medium and add to the tube.
- Centrifuge for 10 minutes at 300 x g. Aspirate the supernatant.
- Resuspend the cell pellet with 10 mL of StemSpan™ HSPC Medium.
- Centrifuge for 10 minutes at 300 x g. Aspirate the supernatant and resuspend the cell pellet in a small volume of StemSpan™ HSPC Medium.
Note: Thorough washing is critical for removing residual cryoprotectant, as it may negatively impact cell viability and expansion performance.
- Proceed to Cell Counting and Seeding of CD34+ HSPCs (Day 0) to begin expansion.
Cell Counting and Seeding of CD34+ HSPCs (Day 0)
Determine viable cell counts and calculate the volume of cell suspension required to achieve the recommended seeding density for your cultureware of choice (Table 2).
- Pre-warm complete medium to room temperature (15 - 25°C).
- Mix the CD34+ cell suspension and transfer 50 µL to an Eppendorf tube.
- Add 2.5 µL Solution 18 to the Eppendorf tube, and mix thoroughly. Load 31 µL of this cell sample into the chamber of your sampling slide.
- Perform viable cell count using the Nucleocounter® NC-250™. (Alternatively, use your preferred viable cell counting method in place of Steps 1 - 3.)
- To determine the concentration of CD34+ cells, multiply the viable cell count by the percentage of CD34+ cells.
- Prepare cultures at a final density of 1 x104 live CD34+ cells/mL using the volumes shown in Table 2.
- Add the appropriate volume of pre-warmed complete medium to each well or vessel.
- Add the calculated volume of cell suspension to achieve the recommended seeding density and final culture volume shown in Table 2.
- Incubate at 37°C and 5% CO2.
Table 2. Recommended Seeding Densities and Volumes for HSPC Expansion in Various Cultureware
** Both tissue culture-treated and non-tissue culture-treated are suitable for HSPC expansion.
Medium Top-Up (Day 3 or 4)
Perform a 50% medium top-up on either Day 3 or 4 as follows.
- Pre-warm freshly-made complete medium to room temperature (15 - 25°C).
- Without removing spent medium, add fresh complete medium equal to the initial culture volume (refer to Table 2 for cultureware-specific volumes).
Note: Medium is added to maintain a cell concentration < 1 x 105 cells/mL.
- Incubate at 37°C and 5% CO2.
Harvesting CD34+ HSPCs (Day 7)
Expanded CD34+ HSPCs are typically harvested on Day 7. A 7-day culture period provides an optimal balance between cell yield, CD34 expression, and progenitor cell function. Shorter culture periods of 24 - 72 hours may be used when preservation of stem and progenitor cell function is prioritized over cell yield. Culturing durations longer than 7 days may increase total cell yield but can result in reduced CD34 expression and progenitor cell function due to differentiation.
If culturing beyond Day 7, continue cultures with periodic dilution every 3 - 4 days to maintain cell concentrations below 1 x 105 cells/mL.
- Image the culture if desired.
- Pipette the culture 2 - 3 times to fully resuspend cells. Transfer the entire cell suspension to a collection tube.
- Rinse wells with StemSpan™ HSPC Medium and pipette into the same collection tube to ensure all cells are collected.
- Centrifuge the collected cell suspension at 300 x g for 5 - 10 minutes.
- Aspirate the supernatant and resuspend the cell pellet in StemSpan™ HSPC Medium for cell counting and downstream assays.
- Determine viable cell counts using an automated cell counting method or a preferred method.
Note: It is recommended to use automated viable cell counts (e.g. Viability and Cell Count Assay on the ChemoMetec Nucleocounter® NC-250™) to reduce variability.
- Optional: Cryopreserve expanded CD34+ HPSCs for future use.
- Optional: Assess cell phenotype by flow cytometry using hematopoietic markers such as: CD34, CD45RA, CD38, CD90 and EPCR.
Note: Antigen expression on cultured cells may not be as predictive of stem cell status or lineage potential as antigen expression on freshly isolated CD34+ cells. For example, although the CD34+CD38- phenotype is highly enriched for hematopoietic stem cells and primitive progenitor cells in non-cultured samples, cultured CD34+CD38- cells may not retain the same degree of primitiveness.
- Optional: Assess the functional potential of expanded CD34+ HSPCs using colony forming-unit (CFU) assays. MethoCult™ H4435 Enriched medium may be used for CFU culture and analysis.
Data Figures
The following figures demonstrate phenotypic and functional characterization of human CD34+ HSPCs expanded in StemSpan™ HSPC Medium supplemented with StemSpan™ CD34+ Expansion Supplement and UM729, as described in this protocol. Flow cytometry analysis shows phenotype of expanded CD34+ HSPCs and primitive CD34+CD45RA-CD90+EPCR+ HSCs, while CFU assays demonstrate retention of multilineage progenitor function.
Figure 1. Gating Strategy for Immunophenotype Analysis of CD34+ Cells Cultured for 7 Days with StemSpan™ HSPC Medium
Purified CD34+ cells derived from cord blood (CB) were cultured for 7 days in StemSpan™ HSPC Medium supplemented with StemSpan™ CD34 Expansion Supplement and UM729. Following culture, cells were stained with fluorescently labeled antibodies against CD34, CD45RA, CD90, and EPCR, along with the viability dye 7-AAD, and analyzed by flow cytometry to identify hematopoietic stem and progenitor cell (HSPC) subsets. A sequential gating strategy was applied to define phenotypically distinct populations. (A) Live CD34+ cells were first identified, followed by (B) resolution of CD45RA and CD90 expression within the CD34+ population. (C) The CD34+CD45RA-CD90+ subset was then further analyzed for EPCR expression to identify a primitive HSPC population. Fluorescence minus one (FMO) controls were used to define gating boundaries.
Figure 2. StemSpan™ HSPC Medium Supports Robust Expansion of CD34+ Hematopoietic Stem and Progenitor Cells from Multiple Sources
Purified CD34+ cells derived from cord blood (CB), mobilized peripheral blood (mPB), and bone marrow (BM) were resuspended at 10,000 cells/mL (CB) or 20,000 cell/mL (mPB and BM) in StemSpan™ HSPC Medium supplemented with StemSpan™ CD34 Expansion Supplement and UM729. After 7 days of culture, cells were harvested and analyzed by flow cytometry to determine the frequency and yield of CD34+ cells. Frequency (left) and yield (right) of CD34+ cells are shown. Data are represented as mean ± SEM (n = 74, 7, and 7 for CB, mPB and BM, respectively.
Figure 3. StemSpan™ HSPC Medium Supports Expansion of CD34+CD45RA-CD90+EPCR+ Hematopoietic Stem Cells from Multiple Sources
Purified CD34+ cells derived from cord blood (CB), mobilized peripheral blood (mPB), and bone marrow (BM) were resuspended at 10,000 cells/mL (CB) or 20,000 cell/mL (mPB and BM) in StemSpan™ HSPC Medium supplemented with StemSpan™ CD34 Expansion Supplement and UM729. After 7 days of culture, cells were harvested and analyzed by flow cytometry for expression of CD34, CD45RA, CD90, and EPCR to identify hematopoietic stem cell subsets (CD34+CD45RA-CD90+EPCR+). Frequency (left) and yield (right) of CD34+CD45RA-CD90+EPCR+ cells are shown. Data are represented as mean ± SEM (n=74, 7, and 7 for CB, mPB and BM, respectively).
Figure 4. Expanded CD34+ HSPCs Retain Functionality and Multilineage Colony-Forming Potential After 7 Days of Culture in StemSpan™ HSPC Medium
Purified CD34+ cells derived from cord blood (CB), mobilized peripheral blood (mPB), and bone marrow (BM) were cultured for 7 days in StemSpan™ HSPC Medium supplemented with StemSpan™ CD34 Expansion Supplement and UM729. Following culture, cells were seeded at 500 cells/mL into MethoCult™ H4435 Enriched and assessed for colony-forming unit potential using a 14-day colony-forming unit (CFU) assay. Colonies were classified by subtype, including multipotent (CFU-GEMM), myeloid (CFU-G, CFU-M, CFU-GM), and erythroid (BFU-E, CFU-E) lineages. (A) Frequency of each colony subtype derived from CB, mPB and BM expanded cells. Data represent mean ± SEM (n=5, 3, and 3 for CB, mPB, and BM, respectively). Representative images of (B) CB-derived, (C) mPB-derived, and (D) BM-derived CFU cultures; the formed colonies were imaged using շѱDz™.
For more information, explore the StemSpan™ product family, browse related protocols and workflow resources, or discover our complete portfolio of products to support your hematopoietic cell therapy development workflow.
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
This site is protected by reCAPTCHA and the Ի.